FGF19 and hepatocellular carcinoma: In HCC pathogenesis, if FGF19 is amplified, this leads to FGF19 overexpression in the hepatocyte resulting in the activation of this pathway and turning from intestine-driven endocrine to autocrine hepatocellular signaling control [177].